Monlunabant
id:
monlunabant-189-11904183
title:
Monlunabant
text:
Monlunabant is a peripherally selective cannabinoid receptor 1 inverse agonist, discovered as a β-arrestin-2-biased cannabinoid receptor 1 antagonist by the National Institutes of Health. It was developed as a weight loss drug by Inversago Pharma.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Monlunabant
date created:
2023-12-05T01:16:26Z
date modified:
2024-09-09T08:27:58Z
main entity:
{"identifier":"Q123913842","url":"https://www.wikidata.org/entity/Q123913842"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/a4/Monlunabant.svg","width":720,"height":605}
fields total:
13
integrity:
16